What You Need to Know About Roundup Cancer Claims
Corporate mergers and acquisitions happen all the time in the business world. Back in 2018, Bayer paid $63 billion to take over Monsanto. That gave Bayer control over all of Monsanto’s assets and products. It also meant that Bayer inherited all of Monsanto’s legal woes, including the ongoing litigation against Roundup.
Roundup is a popular weed killer used by farmers and home gardeners alike. Its active ingredient is glyphosate.
Back in 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as a probable carcinogen, or cancer-causing element. As a result, thousands of Roundup users who were diagnosed with cancer sued Monsanto.
That brings us back to the Bayer acquisition.
In an effort to “clean house,” Bayer has proposed a $7.25 billion settlement to cover the costs for approximately 65,000 plaintiffs involved in various class-action lawsuits. Bayer would like nothing more than for this to be the end of their troubles. That shifts the burden to all those people who used Roundup and have been diagnosed with cancer to make a legitimate claim.
Pursuing these claims is a complicated process that requires very specific evidence. It also requires the support and guidance of an experienced Morris toxic exposure lawyer. That attorney will be in the best position to help lay out all the available options.